Research: constituent Literature Activity scores (blend; no single score)
Data as of Nov 17, 2026 · Sources: Wikipedia pageviews, Reddit, X public mentions.
Measures online attention only. It is not a measure of quality, purity, efficacy, or safety.
Publications per year
This catalog item is a multi-constituent blend, so there is no honest single-compound PubMed corpus and no publications-per-year chart. Literature Activity is not scored.
This catalog item is a four-constituent blend. There is no honest single-compound PubMed corpus for the finished product, so Literature Activity is not scored and there is no publications-per-year chart. Cards below are constituent literature, clearly labeled as not studies of this blend.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
No single PubChem recordBlend; formula is not assigned
Molecular weight
Not listed as a single massBlend; mass is not assigned
Receptor context
Multi-constituent blend; see constituent pages for receptor contextCatalog identity only
Sequence
Not reproduced hereSee primary literature / PubChem
Researcher access
Sign-in required to view pricing
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Tissue Signaling Research
RC-KLW appears in the PEPTIDEA™ Cellular Signaling Research collection with the single-compound listings RC-GHK, RC-BPC, and RC-TB4, and with the two-constituent listing RC-BPTB4.
Multi-constituent blend; constituent amounts not stated
The vial presentation is 80 mg (SKU RC-701-80). Named constituents in handbook notes are GHK-Cu, BPC-157, TB-500 / thymosin beta-4, and KPV. This page lists those names for identity only and does not assign amounts or a ratio to those constituents. The TB-500 name may refer to full-length thymosin beta-4 or to a shorter fragment; this page does not assign one sequence to the blend.
No blend-level PubMed corpus
Literature cards below are studies or reviews of named constituents. They are not clinical or laboratory trials of this finished blend.
80 mg vial
The catalog presentation is an 80 mg vial. A BAC Water attribute may appear as an add-on field on the product, but it is not a size variation on this page. This is a presentation of the research material, not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
Catalog title
RC-KLW | Tissue Signaling Research
Category
Tissue Signaling Research (Cellular Signaling Research)
Associated names
Named constituents: GHK-Cu; BPC-157; TB-500 / thymosin beta-4; KPV. Ratio and exact TB-500 sequence are not stated on this page.
Format
Lyophilized research peptide blend
Public catalog status
In stock (as of Nov 17, 2026)
Catalog presentations
80 mg vial — sizes of the research material, not a use protocol
Molecular formula
No single PubChem record (Blend; formula is not assigned, retrieved Nov 17, 2026)
Molecular weight
Not listed as a single mass (Blend; mass is not assigned)
InChIKey
Not listed as a single InChIKey (PubChem)
Receptor context
Handbook notes identify the named constituents as GHK-Cu, BPC-157, TB-500 / thymosin beta-4, and KPV. This page lists those names for identity only and does not present amounts, ratios, or a single receptor description as facts about the finished blend.
Sequence
Not reproduced on this page. See primary literature and the PubChem record.
Pricing
Visible after researcher sign-in
No PubChem CID is assigned to the finished blend.
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Review — constituent (GHK-Cu), not the blend
Pickart and Margolina
International Journal of Molecular Sciences · 2018
Survey of published GHK-Cu biochemistry and gene-expression reports
This review surveys published work on the GHK copper tripeptide. It is included because GHK-Cu is a named constituent of this blend, not because the review studied the blend.
Applied or clinical inferences in the review are not restated on this page.
BPC 157 described as a stable gastric pentadecapeptide
This review describes BPC 157 as a stable gastric pentadecapeptide and surveys published laboratory work. It is included because BPC-157 is a named constituent of this blend, not because the review studied the blend.
Wound-healing and other applied wording in the review is not restated on this page. A large share of this literature comes from a single research tradition.
Review — constituent (thymosin beta-4), not the blend
Ying et al.
Current Protein and Peptide Science · 2023
Thymosin beta-4 and actin-binding biochemistry
This review surveys thymosin beta-4 as an actin-binding peptide. It is included because TB-500 / thymosin beta-4 is a named constituent of this blend, not because the review studied the blend. Findings for full-length thymosin beta-4 cannot automatically be applied to a shorter fragment, and this page does not assign one sequence to the blend.
Clinical-application wording in the review is not reproduced here.
Experimental, animal model — constituent (KPV), not the blend
Hiltz and Lipton
FASEB Journal · 1989
A C-terminal fragment of alpha-MSH in experimental inflammation models
This paper examined a C-terminal fragment of the neuropeptide alpha-MSH in experimental inflammation models, work that is part of the early literature on the 11-13 tripeptide KPV. It is included because KPV is a named constituent of this blend, not because the paper studied the blend.
Inflammation-model findings reported in the paper are not restated on this page.
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
Handle as a lyophilized research material intended for laboratory use only.
Store according to the conditions printed on the label and in any compound document provided to approved researchers.
Protect closed vials from moisture and unnecessary temperature swings.
If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
This material is not for human or veterinary use and is not medical advice.
No dosing, administration, or protocol instructions are included on this page.
Related compounds
Other PEPTIDEA™ materials currently listed under Tissue Signaling Research on the public catalog.